Dexamethasone Implants in Patients with Naïve or Refractory Diffuse Diabetic Macular Edema.

@article{EscobarBarranco2015DexamethasoneII,
  title={Dexamethasone Implants in Patients with Na{\"i}ve or Refractory Diffuse Diabetic Macular Edema.},
  author={Jos{\'e} Juan Escobar-Barranco and Bego{\~n}a Pina-Mar{\'i}n and Manel Fern{\'a}ndez-Bonet},
  journal={Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde},
  year={2015},
  volume={233 3-4},
  pages={176-85}
}
PURPOSE To assess the effect of dexamethasone (DEX) 0.7 mg (Ozurdex™) on refractory and treatment-naïve diffuse diabetic macular edema. METHODS A prospective study was conducted in 76 patients (40 refractory and 36 naïve) with visual acuities (VA) of 15-72 ETDRS letters, central macular thickness (CMT) >300 µm and intraocular pressure (IOP) <25 mm Hg. After the DEX implant (±photocoagulation), VA, CMT and total macular volume (TMV) were assessed monthly for 6 months. RESULTS At every visit… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

Diabetes, metabolic syndrome and obesity : targets and therapy • 2015
View 3 Excerpts
Highly Influenced

Dexamethasone Implants in Patients with Naive Diabetic Macular Edema.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde • 2016

Similar Papers

Loading similar papers…